http://www.foxbusiness.com/news/2013/05/23/elan-rejects-latest-royalty-pharma-approach/ http://www.foxbusiness.com/news/2013/05/23/royalty-pharma-lowers-acceptance-threshold-for-elan-offer/ http://www.foxbusiness.com/news/2013/05/21/gilead-hepatitis-c-drug-gets-accelerated-review/ http://www.foxbusiness.com/news/2013/05/20/royalty-pharma-raises-takeover-bid-for-elan/ http://www.foxbusiness.com/news/2013/05/10/sp-highlights-biotech-etfs/ http://www.foxbusiness.com/news/2013/05/03/market-wrap-for-friday-may-3-stocks-jump-on-strong-jobs-data/ http://www.foxbusiness.com/news/2013/04/30/vertex-pharmaceuticals-swings-to-1st-quarter-loss-on-write-down/ http://www.foxbusiness.com/news/2013/04/29/regeneron-pharmaceuticals-co-founder-receives-8155-million-compensation/ http://www.foxbusiness.com/news/2013/04/26/as-biotechnology-stocks-soar-bubble-talk-percolates/ http://www.foxbusiness.com/news/2013/04/23/bristol-says-results-hepatitis-c-drug-trial-are-positive/ http://www.foxbusiness.com/news/2013/04/22/biotech-mutual-funds-show-etfs-are-place-to-be/ http://www.foxbusiness.com/news/2013/04/21/look-ahead-this-week-etfs-to-watch/ http://www.foxbusiness.com/news/2013/04/19/vertex-news-lifts-biotech-etfs/ http://www.foxbusiness.com/news/2013/04/18/vertex-pharmaceuticals-shares-surge-on-cystic-fibrosis-data/ http://www.foxbusiness.com/news/2013/04/15/royalty-pharma-offers-more-for-elan/ http://www.foxbusiness.com/news/2013/04/11/etf-showdown-pharma-fight/ http://www.foxbusiness.com/news/2013/04/11/under-hood-unheralded-biotech-etf/ http://www.foxbusiness.com/news/2013/03/28/biotech-breakout-boosting-etfs/ http://www.foxbusiness.com/news/2013/03/25/moving-averages-indicate-these-sector-etfs-could-be-stretched/ http://www.foxbusiness.com/news/2013/03/22/gentium-gets-negative-opinion-from-chmp-biogen-others-get-positive-opinions/